120 participants
Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-05
- Start Date:
- 2024-12-23
- Completion:
- 2028-12-31
Conditions
- Chronic Graft-versus-host Disease (cGVHD)
Interventions
- DRUG
No Results Yet